Portal
Home
DOXIL®
(doxorubicin HCI
liposome injection)
NUCYNTA® ER
(tapentadol
extended-release tablets)
NUCYNTA®
(tapentadol)
PROCRIT®
(epoetin alfa)
REMICADE®
(infliximab)
SIMPONI®
(golimumab)
STELARA®
(ustekinumab)
XARELTO®
(rivaroxaban)
ZYTIGA®
(abiraterone
acetate)
Janssen Biotech, Inc.
Procrit Billing - Enter Here
State Medicare Guidelines / CMS 1500


Patient Programs

Resources to help patients or caregivers learn more about treatments or financial programs.


Helpful Resources

Publications and toolkits for billing professionals regarding reimbursement issues and processes.
Key Links

Over 400 links to societies and state sites that will help with reimbursement, insurance or specific patient needs.
PROCRIT® (epoetin alfa) is marketed by Janssen Products, LP.

Please see full Prescribing Information, including Boxed WARNING,
for PROCRIT
® (epoetin alfa). The Boxed WARNING is shown below.
Short Cuts

Announcements